Fennec Pharmaceuticals (NASDAQ:FENC – Free Report) had its target price lowered by HC Wainwright from $18.00 to $17.00 in a research note released on Friday morning, MarketBeat.com reports. The firm currently has a buy rating on the stock. Separately, Cantor Fitzgerald raised their price target on Fennec Pharmaceuticals from $12.00 to $16.00 and gave the […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) Director Chris A. Rallis sold 2,207 shares of the firm’s stock in a transaction dated Thursday, July 6th. The stock was sold at an average price of $8.47, for a total transaction of $18,693.29. Following the completion of the transaction, the director now owns 28,826 shares in the […]
Fennec Pharmaceuticals Inc (NASDAQ:FENC – Free Report) Director Chris A. Rallis sold 2,207 shares of the firm’s stock in a transaction dated Thursday, July 6th. The shares were sold at an average price of $8.47, for a total value of $18,693.29. Following the sale, the director now directly owns 28,826 shares in the company, valued […]
Fennec Pharmaceuticals (NASDAQ:FENC – Get Rating)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research report issued on Friday, Benzinga reports. They presently have a $18.00 price objective on the stock. HC Wainwright’s price objective suggests a potential upside of 110.53% from the stock’s current price. Fennec Pharmaceuticals Trading Up […]